logo

Biotech Stocks Facing FDA Decision In September 2019

Pending Drug Approvals
Pending Drug Approvals

So far this year, 25 novel drugs have been approved compared to 35 during the same period last year. It should be noted that 59 novel drugs were approved in the full year 2018, an all-time high for new drug approvals.

Now, let's take a look at the companies that await a ruling from the FDA in September 2019.

Share



>